Caplin Point Labs reappoints Dr C K Gariyali as Independent director

Published On 2023-09-24 04:30 GMT   |   Update On 2023-09-24 04:31 GMT

Chennai: Caplin Point Labs has announced that the members of the company have re-appointed Dr C K Gariyali as an Independent Director of the company for a further period of three years commencing from March 04, 2023. Dr C K Gariyali had served for 28 years as an Indian Administrative Officer in Government of India. During her service as an IAS officer, she had held various positions...

Login or Register to read the full article

Chennai: Caplin Point Labs has announced that the members of the company have re-appointed Dr C K Gariyali as an Independent Director of the company for a further period of three years commencing from March 04, 2023. 

Dr C K Gariyali had served for 28 years as an Indian Administrative Officer in Government of India. During her service as an IAS officer, she had held various positions including the District Collector of Madras and South Arcot, Secretary to Honourable Chief Minister of Tamil Nadu, Principal Secretary to His Excellency the Governor of Tamil Nadu etc. She has a very rich experience in the field of Administration.

Read also: Low BP treatment: Caplin Steriles bags USFDA nod for Norepinephrine Bitartrate Injection

Caplin Point Laboratories Limited is a pharmaceutical Company. The company has state of the art manufacturing facilities that cater to a complete range of finished dosage forms. Caplin Point has appeared on Forbes Asia’s “200 Best Under a Billion” list for an unprecedented 6th time in the last 10 years.

Read also: USFDA nod to Caplin Steriles Cisatracurium Besylate Injection



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News